Search

everythinglearnresearchcommunity

for

Search:↓

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

Tacrolimus is a better option than cyclosporine due to fewer side effects.

Heptaminol may cause hair lightening in hemodialysis patients.

Ethanamizuril is safe for rats at 20 mg/kg feed, but higher doses cause hair loss, organ changes, and liver, kidney, and lung damage.

Cromolyn sodium's effectiveness for treating asthma in children under 2 is unclear, possibly more beneficial for older children, and further research is needed.

Tofacitinib can cause skin eruptions similar to palmoplantar pustulosis.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

0.1% piroctone olamine in hair tonics effectively treats dandruff.

Topiramate may help improve disruptive behaviors in children with bipolar disorder.

Methotrexate and azathioprine are equally effective and well-tolerated for treating lichen planopilaris.

Delonix polymeric nanoparticles with isotretinoin effectively treat acne by targeting hair follicles and reducing skin irritation.

Hydroxychloroquine is less effective than betamethasone oral mini pulse therapy for treating alopecia areata.

Ruxolitinib cream may help treat severe hair loss in children.

Tigason improved hair growth in a boy with monilethrix without side effects.

MK-5108 is safe and shows potential against tumors, especially alone.

A reliable method was developed to measure Minoxidil and Tofacitinib in gel for hair loss treatment.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

Baricitinib may effectively treat lichen planopilaris.

Tofacitinib effectively improved hair regrowth and skin condition in a woman with alopecia totalis and lichen planus hypertrophicus.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Mycophenolate mofetil effectively improved skin pigmentation and itching in a woman with lichen planus pigmentosus and frontal fibrosing alopecia.

Both tofacitinib and ruxolitinib are effective and tolerable for treating alopecia areata.

Intramuscular triamcinolone acetonide is an effective treatment for severe alopecia areata, especially in males.

Oxiconazole nitrate cream is effective and well-tolerated for treating various fungal skin infections.

Cepharanthine dry powder inhalers may effectively treat acute lung injury by reducing inflammation.

Intramuscular triamcinolone and pulse therapy with oral predonine are effective for alopecia areata with manageable side effects, but better relapse prevention is needed.

Baricitinib shows promise for severe alopecia areata but isn't a cure and has side effects.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.